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Abstract
Background: This study aims to determine the role of hematological variables in determin-
ing critical coronary artery stenosis in young adults with myocardial infarction.
Methods: This study includes 76 of 1,804 patients who applied to our hospital between
January 2001 and December 2005. All were under 35 years old, diagnosed as acute myocar-
dial infarction with clinical and laboratory findings, and had coronary angiography. Study
patients were divided into two groups: those having critical coronary artery lesions (group I)
and those having normal coronary arteries (group II). Then we compared these groups for age,
sex, body mass index, risk factors, plasma protein C, protein S, antithrombine III and fibrino-
gen. Student t test, the c2 test, Fisher’s exact test and Mann Whitney U test were used.
Results: There were no differences between the two groups in terms of hypertension (p = 0.70),
smoking (p = 0.50), hyperlipidemia (p = 0.09), body mass index (p = 0.14), family history
(p = 0.10), plasma protein C (p = 0.08), protein S (p = 0.35) or antithrombine III (p = 0.60).
Plasma fibrinogen levels were significantly higher in group I than in group II (p = 0.001).
Conclusions: Our study shows that high plasma fibrinogen levels may be used as a predictor
of critical coronary artery lesions in young patients with acute myocardial infarction.
(Cardiol J 2009; 16, 4: 317–320)
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Introduction
Acute myocardial infarction (AMI) is an irre-
versible myocardial injury and necrosis caused by
serious and long term ischemia. It is generally seen
in middle aged men with high risk factors for coro-
nary artery disease. Only 4% of patients with AMI
are under 40 years of age [1]. Coronary anatomy is
normal in 30% of young AMI patients [2]. The presence
of normal coronary anatomy is related to coronary
vasospasm, embolism from endocardium or heart ves-
sels, platelet aggregation or spontaneous lysis of
thrombus [3]. Due to the high rate of normal coro-
nary angiography in young patients, we wanted to
find parameters predicting early coronary artery le-
sion. So, we aimed to evaluate the relationship be-
tween coronary anatomy and risk factors, clinical
properties, plasma fibrinogen, protein C, protein S,
antithrombine III (AT III) levels to determine co-
ronary artery lesion in patients under 35.
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Methods
Patient population
This study includes 76 of 1,804 patients under
35 years old and admitted to our hospital with a dia-
gnosis of AMI between January 2001 and Decem-
ber 2005. Written informed consent was obtained
from all subjects and the study was approved by the
local bioethical committee. Patients on anticoagu-
lants or who had hematological and connective tis-
sue diseases were excludued.
AMI is diagnosed where there are at least two
of following:
— chest pain longer than 30 minutes which does
not respond to nitrates;
— in 12-lead electrocardiography, a new Q wave
longer than 40 ms and/or ST segment eleva-
tion 0.1 mV on at least two extremity deriva-
tions or 0.2 mV on precordial derivation;
— a 1.5 times, or higher, increase in serum cre-
atin-phosphokinase-MB.
Cardiac catheterization
Coronary angiography was performed with
Phillips Multidiagnosis C2 device using either the
Sones or Judkins technique. Above 50% obstruction
in coronary vessel was accepted as critical coronary
artery stenosis. Left ventriculography was per-
formed with standard techniques. Study patients
were divided into two groups: with critical coronary
artery stenosis (group I) and with normal coronary
arteries (group II), due to their coronary angiogra-
phies.
Analysis of hematological profile
Blood samples were taken four weeks after
myocardial infarction. After clear venipuncture of
an antecubital vein, the blood was put in tubes con-
taining 0.11 M sodium citrate and centrifuged for
20 minutes at 1000 g. The plasma was stored at
–30°C until assayed for proteins C and S and fibri-
nogen (0–12 months). Assay of protein C, protein S
was performed by ELISA (Diagnostica Stago, France)
and AT III by chromogenic substrate method (Diagnos-
tica Stago, France). Fibrinogen levels were deter-
mined by the method of Clauss (Diagnostica Stago,
France). Since fibrinogen levels can be affected
by AMI, it was studied after four weeks of AMI.
We evaluated the presence of hypertension
(systolic blood pressure; 140 mm Hg and/or diastolic
blood pressure; 90 mm Hg and/or receiving antihy-
pertensive agents), hyperlipidemia (serum total
cholesterol level; 220 mg/dl, or 5.69 mmol/L,
and/or triglyceride level; 150 mg/dL, or 1.70 mmol/L,
and/or receiving lipid-lowering agents), diabetes
mellitus (plasma glucose; 127 mg/dL, or 7.06 mmol/L,
and/or receiving glucose-lowering agents).
Groups were compared for hypertension, dia-
betes mellitus, hyperlipidemia, smoking, family his-
tory, age, sex, body mass index, plasma fibrinogen,
protein C, protein S and AT III levels.
Statistical analysis
Quantitative values are expressed as mean ± SD
and were compared using unpaired Student t test.
The c2 test, Fisher’s exact test and Mann Whitney U
test were used to analyze categorical data. For all
tests, p > 0.05 was designated nonsignificant, and
a value of p < 0.05 was considered statistically sig-
nificant. The Statistical Package for Social Scienc-
es (SPSS) statistical software package (version 10.0,
Inc., Chicago, USA) was used to perform all statis-
tical calculations.
Results
Seventy six of 1,804 patients were under
35 years old. All were male, with an average age of
30.2 ± 4.8 years. None had diabetes mellitus. Ac-
cording to the coronary angiography, 47% (group II,
n = 36) had normal coronary arteries and 53%
(group I, n=40) had critical coronary artery steno-
sis. In group I, 32 cases had one, six had two and
two had three-vessel diseases. There were no sig-
nificant differences between the two groups in
terms of hypertension (p = 0.70), smoking (p = 0.50),
hyperlipidemia (p = 0.09), protein C (p = 0.08), pro-
tein S (p = 0.35), AT III (p = 0.60), body mass in-
dex (p = 0.14), or family history (p = 0.10). Plasma
fibrinogen levels were significantly higher in group
I than in group II (p = 0.001) (Tables 1 and 2).
Discussion
Our study showed that high plasma fibrin-
ogen levels may be used as a predictor of coro-
nary artery lesions in young patients with AMI.
Acute myocardial infarction is generally caused
by thrombus arising secondary to the rupture
of the atherosclerotic plaque in coronary artery
and usually affects adults over 40. Only 4% of
AMI patients are under 40 [1, 4]. Young patients
have different characteristics in terms of risk
factors profile, physiopathological mechanisms,
clinical presentation, angiographic findings and
prognosis.
Some researchers have claimed that the pres-
ence of normal coronary anatomy in young patients
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with AMI is 17–30% [2, 3]. According to them, nor-
mal coronary arteries after AMI is related to coro-
nary vasospasm, embolus arising from endocardium
or heart vessels, platelet aggregation, coronary ar-
tery lesions invisible by angiography or spontane-
ously lysised thrombus [5]. In our study, we also
found that 47% had normal coronary arteries, 42%
had one-vessel, 8% had two-vessel and 3% had
three-vessel disease.
Smoking is the most important and common-
est risk factor in young patients. It is reported that
smoking is a risk factor in 24–56% of patients with
AMI over the age of 40 and in 73–90% of patients
under 40 with AMI [6]. Smoking is the commonest
risk factor in myocardial infarction patients with
normal coronary anatomy. Smoking impairs en-
dothelium derived vasodilatory mechanisms and
causes vasospasm in coronary arteries [7, 8]. Va-
sospasm is supposed to be the most important phys-
iopathological mechanism in these patients [9, 10].
Family history is another important risk factor for
early coronary artery disease [11]. In our study, we
found that smoking and early coronary artery dis-
ease positive in 80% and 30% of patients respec-
tively. Clinical presentation of coronary artery dis-
ease in young adults is generally AMI, and this may
be a consequence of more complex coronary artery
lesions [12]. Disorders involving coagulation sys-
tem should also be considered in the ethiology.
Protein S is an endothelium derived protein C co-
factor and both proteins function as coagulation in-
hibitors. Lack of these proteins, AT III and high
levels of plasminogen activator inhibitor-1 may
be responsible for AMI [13, 14].
In a study comparing young AMI patients to
normal healthy cases, there were no significant dif-
ferences in protein C, protein S, plasminogen,
AT III and factor VII levels among the coronary
artery lesion group, the normal coronary artery
group and the normal healthy group [15]. We stud-
ied these haemotological risk factors, but we also
could not find any significant difference in protein C,
S and AT III levels between our two groups.
Meade et al. [16] first reported an association
between hemostatic parameters and cardiovascu-
lar death. In their prospective study, they found that
people who died of coronary heart disease had high-
er plasma levels of fibrinogen on presentation com-
pared to the patients who survived. They also
showed that the association of cardiovascular mor-
tality with fibrinogen levels was independent of
established coronary heart disease risk factors and
stronger than the association with serum choles-
terol. Lowe et al. [17] reported that levels of fibrin-
ogen were higher in patients with two or three sten-
osed coronary arteries than in those with a single
stenosed artery or no stenosis. Wilhelmsen et al.
[18] reported on the synergistic effect of fibrinogen
levels and blood pressure on stroke and suggested
that high plasma fibrinogen is a risk factor for stroke
and myocardial infarction.
Recently it has been demonstrated that plas-
ma fibrinogen is significantly associated with a high
quantity of coronary artery calcifications, a marker
of preclinical coronary atherosclerosis [19]. Fibri-
nogen is also involved in a number of mechanisms
(endothelial cell injury, platelet aggregation, and
plasma viscosity) that play a central role in the for-
mation of thrombi: first, it is an important determi-
nant of platelet aggregation, binding to the platelet
membrane glycoprotein receptor IIb/IIIa; second-
ly, fibrinogen plays a crucial role in the coagulative
process since it represents the physiological sub-
strate of thrombin, hyperfibrinogenemia may induce
a hypercoagulative state by a procoagulant imbalance,
leading to the formation of insoluble fibrin [20, 21];
thirdly, fibrinogen, due to its large and elongated
molecular form and to its binding capacity, is the
Table 1. Clinical characteristics and prevalence
of conventional coronary risk factors in group I
and group II; p > 0.05.
Parameters Group I Group II
(n = 40)  (n = 36)
Age 30.6 ± 4.4 31.2 ± 4.8
Hypertension 14 (35%) 10 (28%)
Hyperlipidemia 20 (50%) 14 (39%)
Smoking 32 (80%) 36 (100%)
Family history 12 (30%) 8 (22%)
Body mass index [kg/m2] 29.1 ± 3.9 28.6 ± 4.0
Table 2. Comparison of hemotological parameters
in group I and group II.
Hemotological Group I Group II P
parameters  (n = 40)  (n = 36)
Fibrinogen 410.8± 298.3± 0.001
[mg/dL] ± 116.9 ± 78.2
Protein C 128 126 > 0.05
(%, activity) (122–133)  (124–130)
Protein S 128 120 > 0.05
(%, activity) (120–128)  (117–124)
Antithrombine III 109 108 > 0.05
(%, activity)  (107–111)  (106–110)
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major determinant of blood viscosity, decreasing
microcirculatory blood flow and capillary blood flow
velocity, thus favoring leukocyte and red blood cell
adhesion with consequent microvascular ischemia.
The importance of hyperfibrinogenemia as
a risk factor for atherothrombosis is confirmed by
a number of previous studies showing an associa-
tion between high fibrinogen levels and other risk
factors for cardiovascular disease including age,
smoking, cholesterol, physical inactivity, arterial
hypertension, diabetes [22–24], angiographically
determined number and severity of coronary ste-
nosis [25, 26].
Our study found that plasma fibrinogen level
in young patients with myocardial infarction and
significant coronary artery lesion is higher than
young patients with myocardial infarction who have
normal coronary arteries.
Limitations of the study
There may be two limitations for this study.
Normal coronary arteries were described by coro-
nary angiography; intravascular ultrasonography
was not used. Secondly, the number of patients in
our study was relatively small.
Conclusions
High plasma fibrinogen levels may be used as
a predictor of critical coronary artery stenosis in
young patients with AMI. We suggest our findings
should be supported by larger studies before being
put into practice.
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